Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Metagenome sequencing of bacteria, fungi, and yeasts present in more than 2,500 foods

An international team with Spanish participation has developed a database with the metagenome of bacteria, fungi, and yeasts present in more than 2,500 foods, mostly dairy products, followed by beverages and fermented meats. The authors identified more than 10,800 microorganisms, half of which were previously unknown species. The study, published in Cell, shows that food-associated microorganisms are present in 3% of the adult gut microbiome and 56% of that of newborns.

0

High-risk Human Papillomavirus (HPV) genotypes linked to reduced male fertility

The sperm of men infected with high-risk genotypes of the human papillomavirus (HPV) suffers more damage from oxidative stress and has a weaker immune response, which can lead to reduced fertility. This is one of the conclusions of a study published in the journal Frontiers in Cellular and Infection Microbiology. The research compared the semen of 20 adults infected with high-risk genotypes, seven infected with low-risk genotypes, and 43 adults without infections.

0

A small share of climate policies significantly reduced emissions

Analysis of 1,500 climate policies implemented in 41 countries over the last two decades - between 1998 and 2022 - shows that a small proportion - 63 of them - achieved a significant reduction in carbon dioxide emissions. The study, published in Science, indicates that a significant decrease in these emissions was recorded in the transport sector in Spain. According to the authors, the combination of several policy instruments is often more effective than the use of single measures.

0

Climate change and an ageing population will accentuate disparities in heat and cold deaths in Europe

A modelling study published in The Lancet Public Health using data from 854 European cities estimates that heat-related deaths will triple in Europe by 2100 under current climate policies. A slight decrease in cold-related deaths is projected, while heat-related deaths will increase in all parts of Europe. The most affected areas will include Spain, Italy, Greece and parts of France. Currently, around eight times as many people in Europe die from cold as from heat, but this proportion is projected to decrease considerably by the end of the century.

0

Study reviews adverse reaction reports for semaglutide and suicide

In research using a WHO database of adverse drug reactions, the authors identified a signal of disproportionality of suicidal ideation with semaglutide, one of the drugs used to treat type 2 diabetes and obesity. The study, published in JAMA Network Open, did not find this signal for liraglutide, another drug indicated for these treatments.

0

The EU considers the risk of mpox spreading to the general population ‘low’ and does not rule out more imported cases

With the increase in cases of mpox, the European Union's Health Security Committee met on Monday. According to the Ministry of Health, the meeting concluded ‘with recommendations very similar to those previously issued by the WHO and the ECDC’. The risk of the likelihood of mpox spreading to the general EU population is currently considered to be ‘low’, although it increases in populations with close contact with diagnosed cases and in particularly vulnerable people. Further imported cases in the EU are not excluded and vaccination of the general population is not recommended. In addition, the HSC does not recommend border control.  
 

0